KPCB closes $525 million fund

Friday, May 18, 2012 12:30 PM

Kleiner Perkins Caufield & Byers (KPCB) has successfully closed the KPCB 15, a $525 million venture capital fund focusing on investments in early-stage digital consumer and enterprise, green tech and life sciences companies.

The fund will be led by 10 managing members, including: Mike Abbott, Chi-Hua Chien, Amol Deshpande, John Doerr, Bing Gordon, Wen Hsieh, Randy Komisar, Matt Murphy, Beth Seidenberg and Ted Schlein.

"Portfolio companies in KPCB 15 will benefit from the firm's holistic approach to company building that we pioneered more than a decade ago," said Schlein, partner at KPCB. "We will identify promising early-stage companies in our areas of focus and bring value-added resources in key areas to help early-stage companies grow and succeed. This includes applying our considerable industry, operational and financial expertise and network of relationships to help entrepreneurs build lasting enterprises."

By providing portfolio companies support in recruitment and talent management, building strategic relationships, as well as expertise in operations, marketing and communications, KPCB furthers the growth and success of its portfolio companies. Portfolio companies will also benefit from recently added hires to the partnership that bring expertise in mobile, social and cloud, including Mary Meeker, Abbott and Gordon.

KPCB's recent early-stage investments include Zynga, RPX, Flipboard, One Kings Lane, Path, Puppet Labs, Nebula, Nest, Aquion Energy, Auxogyn and Foundation Medicine, in addition to many others across its focus areas of digital, green tech and life sciences.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs